These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8611058)

  • 41. Cue exposure with coping skills training and communication skills training for alcohol dependence: 6- and 12-month outcomes.
    Rohsenow DJ; Monti PM; Rubonis AV; Gulliver SB; Colby SM; Binkoff JA; Abrams DB
    Addiction; 2001 Aug; 96(8):1161-74. PubMed ID: 11487422
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
    Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
    Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nalmefene. Alcohol dependence: no advance.
    Prescrire Int; 2014 Jun; 23(150):150-2. PubMed ID: 25121147
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients.
    Zarkin GA; Bray JW; Aldridge A; Mitra D; Mills MJ; Couper DJ; Cisler RA;
    Arch Gen Psychiatry; 2008 Oct; 65(10):1214-21. PubMed ID: 18838638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Building better cognitive-behavioral therapy: is broad-spectrum treatment more effective than motivational-enhancement therapy for alcohol-dependent patients treated with naltrexone?
    Davidson D; Gulliver SB; Longabaugh R; Wirtz PW; Swift R
    J Stud Alcohol Drugs; 2007 Mar; 68(2):238-47. PubMed ID: 17286342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.
    Bouza C; Angeles M; Muñoz A; Amate JM
    Addiction; 2004 Jul; 99(7):811-28. PubMed ID: 15200577
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integration of opioid antagonists and psychosocial therapy in the treatment of narcotic and alcohol dependence.
    O'Malley SS
    J Clin Psychiatry; 1995; 56 Suppl 7():30-8. PubMed ID: 7673103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors for the efficacy of naltrexone treatment in alcohol dependence: sweet preference.
    Laaksonen E; Lahti J; Sinclair JD; Heinälä P; Alho H
    Alcohol Alcohol; 2011; 46(3):308-11. PubMed ID: 21266377
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cloninger's typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone.
    Kiefer F; Jiménez-Arriero MA; Klein O; Diehl A; Rubio G
    Addict Biol; 2008 Mar; 13(1):124-9. PubMed ID: 17573782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study).
    Morley KC; Kranzler HR; Luquin N; Baillie A; Shanahan M; Trent R; Teesson M; Haber PS
    Trials; 2018 Aug; 19(1):443. PubMed ID: 30115121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes.
    Donovan DM; Anton RF; Miller WR; Longabaugh R; Hosking JD; Youngblood M;
    J Stud Alcohol Drugs; 2008 Jan; 69(1):5-13. PubMed ID: 18080059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers.
    Davidson D; Saha C; Scifres S; Fyffe J; O'Connor S; Selzer C
    Addict Behav; 2004 Aug; 29(6):1253-8. PubMed ID: 15236831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outpatient cognitive behavioural therapy programme for alcohol dependence: impact of naltrexone use on outcome.
    Feeney GF; Young RM; Connor JP; Tucker J; McPherson A
    Aust N Z J Psychiatry; 2001 Aug; 35(4):443-8. PubMed ID: 11531723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking.
    Anton RF; Drobes DJ; Voronin K; Durazo-Avizu R; Moak D
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):32-40. PubMed ID: 14722705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Naltrexone's effect on cue-elicited craving among alcoholics in treatment.
    Monti PM; Rohsenow DJ; Hutchison KE; Swift RM; Mueller TI; Colby SM; Brown RA; Gulliver SB; Gordon A; Abrams DB
    Alcohol Clin Exp Res; 1999 Aug; 23(8):1386-94. PubMed ID: 10470982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nalmefene, Given as Needed, in the Routine Treatment of Patients with Alcohol Dependence: An Interventional, Open-Label Study in Primary Care.
    Castera P; Stewart E; Großkopf J; Brotons C; Brix Schou M; Zhang D; Steiniger Brach B; Meulien D;
    Eur Addict Res; 2018; 24(6):293-303. PubMed ID: 30485854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical predictors of response to naltrexone in alcoholic patients: who benefits most from treatment with naltrexone?
    Rubio G; Ponce G; Rodriguez-Jiménez R; Jiménez-Arriero MA; Hoenicka J; Palomo T
    Alcohol Alcohol; 2005; 40(3):227-33. PubMed ID: 15797885
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials.
    O'Malley SS; Rounsaville BJ; Farren C; Namkoong K; Wu R; Robinson J; O'Connor PG
    Arch Intern Med; 2003 Jul; 163(14):1695-704. PubMed ID: 12885685
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeted naltrexone treatment of early problem drinkers.
    Kranzler HR; Tennen H; Penta C; Bohn MJ
    Addict Behav; 1997; 22(3):431-6. PubMed ID: 9183513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Naltrexone in the treatment of alcohol dependence.
    Krystal JH; Cramer JA; Krol WF; Kirk GF; Rosenheck RA;
    N Engl J Med; 2001 Dec; 345(24):1734-9. PubMed ID: 11742047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.